Bupropion Hydrochloride Related Compound A

Pharmaceutical Secondary Standard; Certified Reference Material

2-(tert-Butylamino)-4′-chloropropiophenone hydrochloride, 2-(tert-butylamino)-3’-bromopiophenone hydrochloride
Empirical Formula (Hill Notation):
C13H18ClNO · HCl
CAS Number:
Molecular Weight:
Pricing and availability is not currently available.

Quality Level


certified reference material
pharmaceutical secondary standard


current certificate can be downloaded


pkg of 30 mg


HPLC: suitable
gas chromatography (GC): suitable

Featured Industry

Pharmaceutical (small molecule)



pharmacopeia traceability

traceable to USP 1078744

Looking for similar products? Visit Product Comparison Guide

General description

Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Bupropion hydrochloride (BUP) and its derivatives belong to a chemical class of aminoketones and are known for their antidepressant abilities. BUP selectively inhibits the neuronal reabsorption of catecholamines (noradrenalin and dopamine), has minimal effect on the recapture of indolamines (serotonin) and no inhibitory effect on monoamine oxidase. It is used as the non-nicotine pharmacological therapy for combating smoking in controlled release form.
Bupropion hydrochloride (BUP) may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by spectrophotometric and chromatographic techniques.


These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Analysis Note

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

Other Notes

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.


To see an example of a Certificate of Analysis for this material enter LRAA7916 in the slot below. This is an example certificate only and may not be the lot that you receive.


Exclamation mark

Signal Word


Hazard Statements


NONH for all modes of transport

WGK Germany


Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificate of Analysis
Certificate of Origin
Structures from powders: Bupropion hydrochloride
Maccaroni E, et al
Journal of Pharmaceutical and Biomedical Analysis, 50(2), 257-261 (2009)
Use of charge transfer complexation reaction for the spectrophotometric determination of bupropion in pharmaceuticals and spiked human urine.
Basavaiah K and Abdulrahman SAM
The Thai Journal of Pharmaceutical Sciences, 34(4), 257-261 (2010)
Determination of bupropion using liquid chromatography with fluorescence detection in pharmaceutical preparations, human plasma and human urine
Ulu ST and Tuncel M
Journal of Chromatographic Science, 50(5), 433-439 (2012)
Titrimetric and spectrophotometric assay of bupropion hydrochloride in pharmaceuticals using mercury (II) nitrate
Abdulaziz MA, et al.
Ecletica Quimica , 35(3), 9-16 (2010)
Spectroscopic investigations on the inclusion interaction between hydroxypropyl-β-cyclodextrin and bupropion
Misiuk W and Zalewska M
Journal of Molecular Liquids, 159(3), 220-225 (2011)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.